Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
October 04, 2023 08:00 ET
|
Standard BioTools Inc.; SomaLogic, Inc.
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest...
Standard BioTools Reports Second Quarter 2023 Financial Results
August 08, 2023 16:05 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) (“Standard BioTools”, or the “Company”), driven by a bold purpose – Unleashing tools to accelerate...
Standard BioTools to Participate in Upcoming Investor Conferences
July 26, 2023 16:05 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results
July 25, 2023 16:05 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools to Participate in Upcoming Investor Conferences
June 14, 2023 07:30 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools to Present at the Jefferies Healthcare Conference
May 25, 2023 16:05 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System
May 18, 2023 07:30 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 15, 2023 07:30 ET
|
Standard BioTools Inc.
Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif., May 15, 2023 ...
Standard BioTools Reports First Quarter 2023 Financial Results
May 09, 2023 16:05 ET
|
Standard BioTools Inc.
Net cash used in operating activities of $8.5 million, a 55.8% sequential decline from $19.2 million in the fourth quarter and a 46% reduction from the $15.6 in the first quarter last year GAAP...
Standard BioTools Announces Conference Call and Webcast for First Quarter 2023 Financial Results
April 25, 2023 16:30 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...